Prenatal High-Sucrose Diet Induced Vascular Dysfunction in Thoracic Artery of Fetal Offspring

Mol Nutr Food Res. 2021 Jun;65(12):e2100072. doi: 10.1002/mnfr.202100072. Epub 2021 May 10.

Abstract

Scope: Maternal nutrition during pregnancy is related to intrauterine fetal development. The authors' previous work reports that prenatal high sucrose (HS) diet impaired micro-vascular functions in postnatal offspring. It is unclear whether/how prenatal HS causes vascular injury during fetal life.

Methods and results: Pregnant rats are fed with normal drinking water or 20% high-sucrose solution during the whole gestational period. Pregnant HS increases maternal weight before delivery. Fetal thoracic aorta is separated for experiments. Angiotensin II (AII)-stimulated vascular contraction of fetal thoracic arteries in HS group is greater, which mainly results from the enhanced AT1 receptor (AT1R) function and the downstream signaling. Nifedipine significantly increases vascular tension in HS group, indicating that the L-type calcium channels (LTCCs) function is strengthened. 2-Aminoethyl diphenylborinate (2-APB), inositol 1,4,5-trisphosphate receptors (IP3Rs) inhibitor, increases vascular tension induced by AII in HS group and ryanodine receptors-sensitive vascular tone shows no difference in the two groups, which suggested that the activity of IP3Rs-operated calcium channels is increased.

Conclusion: These findings suggest that prenatal HS induces vascular dysfunction of thoracic arteries in fetal offspring by enhancing AT1R, LTCCs function and IP3Rs-associated calcium channels, providing new information regarding the impact of prenatal HS on the functional development of fetal vascular systems.

Keywords: L-type calcium channels; fetal offspring; inositol 1,4,5-trisphosphate receptors; prenatal high-sucrose; vascular dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Body Weight / drug effects
  • Dietary Sucrose / adverse effects*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / embryology
  • Endothelium, Vascular / physiopathology
  • Female
  • Litter Size
  • Losartan / pharmacology
  • Male
  • Maternal Nutritional Physiological Phenomena
  • Nitric Oxide Synthase Type III / metabolism
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / metabolism
  • Receptor, Angiotensin, Type 2 / metabolism
  • Thoracic Arteries / drug effects*
  • Thoracic Arteries / embryology*
  • Thoracic Arteries / physiopathology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Dietary Sucrose
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Losartan